CRAFTPORT CANNABIS CORP.
Craftport Cannabis Corp. engages in the production and sale of recreational cannabis under the Craftport Cannabis brand in Canada. The company was formerly known as Benchmark Botanics Inc. and changed its name to Craftport Cannabis Corp. in November 2021. Craftport Cannabis Corp. is headquartered in Peachland, Canada.
CRAFTPORT CANNABIS CORP. (BBW0) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, CRAFTPORT CANNABIS CORP. (BBW0) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
CRAFTPORT CANNABIS CORP. - Net Assets Trend (None–None)
This chart illustrates how CRAFTPORT CANNABIS CORP.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CRAFTPORT CANNABIS CORP. (None–None)
The table below shows the annual net assets of CRAFTPORT CANNABIS CORP. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to CRAFTPORT CANNABIS CORP.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
CRAFTPORT CANNABIS CORP. Competitors by Market Cap
The table below lists competitors of CRAFTPORT CANNABIS CORP. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
First Helium Inc
OTCQB:FHELF
|
$207.47 |
|
Belle Corp
PSE:BEL
|
$207.65 |
|
SANLAM AFRICA CORE REAL ESTATE INVESTMENTS LTD (CLASS A SHARES) - (USD)
SEM:SARE
|
$208.56 |
|
Oak Woods Acquisition Corporation Warrant
NASDAQ:OAKUW
|
$208.61 |
|
Solar Philippines Nueva Ecija Corp
PSE:SPNEC
|
$207.05 |
|
MedApp S.A
WAR:MDA
|
$206.39 |
|
El Kahera Housing
EGX:ELKA
|
$206.31 |
|
EPE Special Opportunities Limited
LSE:ESO
|
$206.21 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CRAFTPORT CANNABIS CORP.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares CRAFTPORT CANNABIS CORP.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently CRAFTPORT CANNABIS CORP. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares CRAFTPORT CANNABIS CORP.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $9,244,379,027
- Average return on equity (ROE) among peers: -92.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CRAFTPORT CANNABIS CORP. (BBW0) | €- | N/A | N/A | $207.26 |
| 26U (26U) | $6.75 Million | -514.32% | 1.08x | $248.33K |
| 27N0 (27N0) | $11.56 Million | -0.93% | 0.00x | $4.66K |
| China Resources Pharmaceutical Group Limited (640) | $90.18 Billion | 4.60% | 1.68x | $940.63 Million |
| CIG WIRELESS (6CW) | $27.09 Million | -110.19% | 3.19x | $56.65 Million |
| Solasia Pharma K.K (9SO) | $1.16 Billion | -167.91% | 0.18x | $34.42 Million |
| Apontis Pharma AG (APPH) | $3.46 Million | -34.21% | 7.59x | $11.70 Million |
| Akebia Therapeutics Inc (AX9) | $635.93 Million | -22.58% | 0.57x | $283.56 Million |
| Biofrontera AG (B8FK) | $-12.89 Million | 0.00% | 0.00x | $3.86 Million |
| AVALA RES (CVJ) | $91.87 Million | -27.32% | 0.11x | $113.22K |
| Deciphera Pharmaceuticals Inc (D05) | $341.69 Million | -52.37% | 0.33x | $2.11 Billion |